NDatalyzeNDATF ROE % is -104.48% as of Feb. 2026. Among 625 Healthcare Providers & Services companies, NDatalyze ranks worse than 88.32% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. NDatalyze's annualized net income for the quarter that ended in Feb. 2026 was $-0.28 Mil. NDatalyze's average Total Stockholders Equity over the quarter that ended in Feb. 2026 was $0.27 Mil. Therefore, NDatalyze's annualized ROE % for the quarter that ended in Feb. 2026 was -104.48%.
The historical rank and industry rank for NDatalyze's ROE % or its related term are showing as below:
NDATF'
s ROE % Range Over the Past 10 Years
Min: -111.9 Med: -88.53 Max: -8.43
Current: -47.59
During the past 8 years, NDatalyze's highest ROE % was -8.43%. The lowest was -111.90%. And the median was -88.53%.
NDATF's ROE % is ranked worse than 88.32% of 625
companies
in the Healthcare Providers & Services industry
Industry Median: 5.84
vs NDATF: -47.59
NDatalyze (OTCPK:NDATF) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Feb. 2026) net income data. The Revenue data used here is four times the quarterly (Feb. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
NDatalyze ROE % Related Terms
NDatalyze ROE % Historical Data
* Premium members only.
The historical data trend for NDatalyze's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, NDatalyze's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NDatalyze ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NDatalyze's ROE % distribution charts can be found below:
* The bar in red indicates where NDatalyze's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Feb. 2026) net income data.
ROE % is displayed in the 30-year financial page.
NDatalyze (NDATF) has a ROE % of -104.48% as of Feb. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on NDatalyze and its competitors. According to the industry distribution chart, NDatalyze ranks #552 out of 625 companies in the Healthcare Providers & Services industry, placing it in the top 88.3%.
Is NDatalyze's ROE % too high?
NDatalyze's current ROE % is -104.48%. Based on the distribution chart, NDatalyze ranks #552 out of 625 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does NDatalyze's ROE % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, NDatalyze ranks #552 out of 625 companies for ROE %. This places NDatalyze in the lower half of its industry. The industry median ROE % is 5.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.84, based on 625 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on NDatalyze and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NDatalyze's current ROE % is -104.48%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NDatalyze stock overvalued right now?
Based on GuruFocus' analysis, NDatalyze (NDATF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.05, compared to a current price of $0.08 — trading 60% above its estimated fair value. The current ROE % is -104.48%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For NDatalyze (NDATF), the current ROE % is -104.48% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NDatalyze Corp develops technologically-based, specialized products, databases, and applications. The YMI division is developing a data-driven consumer mHealth application designed to predict current and future health conditions to lessen the cost of health services and decrease the load on health care services. The MLdelic division is providing a database platform that may be used to predict potential benefits associated with the use of entheogenic compounds within the mental health sector. The Medxtractor division manufactures small-scale bio-extractors that are used to extract essential oils from botanical materials.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NDATF has been successfully added to your 